CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine

Dan Siskind; Anthony W. Russell; Shuichi Suetani; Dylan Flaws; Steve Kisely; Vikas Moudgil; Korinne Northwood; Gail Robinson; James G. Scott; Terry Stedman; Nicola Warren; Karl Winckel; Peter Cosgrove; Andrea Baker

doi:10.1177/20451253211045248

CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine

Dan Siskind, Anthony W. Russell, Shuichi Suetani, Dylan Flaws, Steve Kisely, Vikas Moudgil, Korinne Northwood, Gail Robinson, James G. Scott, Terry Stedman, Nicola Warren, Karl Winckel, Peter Cosgrove, Andrea Baker

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Original language	English
Journal	Therapeutic Advances in Psychopharmacology
Volume	11
DOIs	https://doi.org/10.1177/20451253211045248
Publication status	Published - 2021
Externally published	Yes

ASJC Scopus Subject Areas

Psychology (miscellaneous)
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Keywords

clozapine
metformin
obesity
randomised controlled trial

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/20451253211045248

Cite this

Siskind, D., Russell, A. W., Suetani, S., Flaws, D., Kisely, S., Moudgil, V., Northwood, K., Robinson, G., Scott, J. G., Stedman, T., Warren, N., Winckel, K., Cosgrove, P., & Baker, A. (2021). CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine. Therapeutic Advances in Psychopharmacology, 11. https://doi.org/10.1177/20451253211045248

CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine. / Siskind, Dan; Russell, Anthony W.; Suetani, Shuichi et al.
In: Therapeutic Advances in Psychopharmacology, Vol. 11, 2021.

Research output: Contribution to journal › Article › peer-review

Siskind, D, Russell, AW, Suetani, S, Flaws, D, Kisely, S, Moudgil, V, Northwood, K, Robinson, G, Scott, JG, Stedman, T, Warren, N, Winckel, K, Cosgrove, P & Baker, A 2021, 'CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine', Therapeutic Advances in Psychopharmacology, vol. 11. https://doi.org/10.1177/20451253211045248

@article{5b0cde13424148ce806a8a76f57e30b4,

title = "CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine",

keywords = "clozapine, metformin, obesity, randomised controlled trial",

author = "Dan Siskind and Russell, {Anthony W.} and Shuichi Suetani and Dylan Flaws and Steve Kisely and Vikas Moudgil and Korinne Northwood and Gail Robinson and Scott, {James G.} and Terry Stedman and Nicola Warren and Karl Winckel and Peter Cosgrove and Andrea Baker",

note = "Publisher Copyright: {\textcopyright} The Author(s), 2021.",

year = "2021",

doi = "10.1177/20451253211045248",

language = "English",

volume = "11",

journal = "Therapeutic Advances in Psychopharmacology",

issn = "2045-1253",

publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - CoMET

T2 - a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine

AU - Siskind, Dan

AU - Russell, Anthony W.

AU - Suetani, Shuichi

AU - Flaws, Dylan

AU - Kisely, Steve

AU - Moudgil, Vikas

AU - Northwood, Korinne

AU - Robinson, Gail

AU - Scott, James G.

AU - Stedman, Terry

AU - Warren, Nicola

AU - Winckel, Karl

AU - Cosgrove, Peter

AU - Baker, Andrea

PY - 2021

Y1 - 2021

KW - clozapine

KW - metformin

KW - obesity

KW - randomised controlled trial

UR - http://www.scopus.com/inward/record.url?scp=85132578224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85132578224&partnerID=8YFLogxK

U2 - 10.1177/20451253211045248

DO - 10.1177/20451253211045248

M3 - Article

AN - SCOPUS:85132578224

SN - 2045-1253

VL - 11

JO - Therapeutic Advances in Psychopharmacology

JF - Therapeutic Advances in Psychopharmacology

ER -

CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this